SoFi Technologies, Inc. (NASDAQ: SOFI) shares are trading higher Thursday amid overall market strength and continued upward momentum. The stock has gained more than 27% over the past month.
What To Know:
Among a biotech space bursting with innovation, one company stands out as it is developing two assets at once: a ready-for-market drink that can take someone from a drinking state to mental and physical composure in record time and a potential breakthrough therapy for Multiple Sclerosis. Meet FSD Pharma (NASDAQ:
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today